Neurology / Neuroscience - Mapping brain functions by fMRI
Can't see this email? View it online
   
  September 24, 2019  
  Neurology / Neuroscience  
  The latest neurology news from News Medical  
 

#ALT# Symposium: Light-Sheet Fluorescence Microscopy for 3D Imaging of Neuronal Samples

Learn about the use of light-sheet fluorescence microscopy in neuronal research and how recent advances in tissue-clearing methods are enabling 3D imaging beyond the realms of other microscopy techniques.

This symposium is a satellite event from SfN 2019, and will take place on Saturday, October 19th, 2019, from 6:30 PM – 10 PM in the Marriott Marquis.

Find Out More
 
 
    KeysightMapping brain functions by fMRI
 
Unraveling brain function remains one of the most challenging aspects of neurology. In this webinar, taking place on September 26, 2019, you will observe real-case studies comparing classical stimulus-driven BOLD detection with manganese-enhanced MRI (MEMRI) on mice and rats.
 
Register Now
 
 
 
    KeysightAdvancing Drug Development for Neuromuscular Diseases
 
Running from October 23 to 25, in Boston, Massachusetts, USA, the Neuromuscular Drug Development (NMD) Summit 2019 will address translational challenges in the field of drug discovery and development for rare neuromuscular diseases.
 
Read Full Article Here
 
 
 Research identifies key molecule that stabilizes neuronal branching for healthy brain circuitry
 
Research identifies key molecule that stabilizes neuronal branching for healthy brain circuitryNeurons form circuits in our brain by creating tree-like branches to connect with each other. Newly forming branches rely on the stability of microtubules, a railway-like system important for the transport of materials in cells.
 
 
 New pathological mediator of ALS found
 
New pathological mediator of ALS foundA research collaboration based in Japan has found a new pathological mediator of amyotrophic lateral sclerosis, which could have further implications for understanding the molecular breakdown that gives rise to the neurodegenerative disease that affects nearly half a million people around the world.
 
 
 Novel protein biomarker can help improve dementia risk prediction
 
Novel protein biomarker can help improve dementia risk predictionIdentifying those who are at risk of dementia, a type of neurodegenerative disease, is crucial for early treatment and development of new therapies, a new study suggests. Dementia affected approximately 46.8 million people across the globe in 2015, and the number increased to close 50 million in 2017. By 2030, the number is expected to soar to 75 million.
 
 
 Chemist explores link between Alzheimer's and copper protein molecules in brain cells
 
Chemist explores link between Alzheimer's and copper protein molecules in brain cellsA University of Houston chemist is exploring the link between copper protein molecules in brain cells and neurodegenerative diseases like Alzheimer's. "Scientists have studied Alzheimer's disease for 100 years and still no one knows the cause," said assistant professor of chemistry Tai-Yen Chen, who will use his $1.9 million award from the National Institute of General Medical Sciences to advance his theory that the balance of copper protein within a single cell may be a culprit.
 
 
 Research reveals new molecular mechanisms that contribute to plasticity of the adult brain
 
Research reveals new molecular mechanisms that contribute to plasticity of the adult brainThe team's findings describe for the first time the changes that take place in the genetic material of excitatory neurons in the hippocampus of adult mice when they activate. An international study headed by researchers of the Neurosciences Institute, mixed center of the Universidad Miguel Hernández (UMH) and the Spanish National Research Council (CSIC), has revealed a new analysis of the changes in the organization of the genetic material of neurons that is triggered by neural activation.
 
 
 Mesh electronics could make brain stimulation the new therapeutic norm
 
Mesh electronics could make brain stimulation the new therapeutic normImplantable brain electrodes have been around for quite some time now, both for diagnosing and treating neuropsychiatric conditions like Parkinson’s disease. However, one limitation of conventional probes is their size and rigidity, compared to the soft, gelatinous consistency of the brain.
 
 
 Neurogenesis plays an underappreciated role in the progression of Alzheimer's
 
Neurogenesis plays an underappreciated role in the progression of Alzheimer'sMuch of the research on the underlying causes of Alzheimer's disease focuses on amyloid beta (Aß), a protein that accumulates in the brain as the disease progresses. Excess Aß proteins form clumps or "plaques" that disrupt communication between brain cells and trigger inflammation, eventually leading to widespread loss of neurons and brain tissue.